CARDIO-RENAL ANEMIA SYNDROME: CORRECTION WITH IRON SUCROSE


Cite item

Full Text

Abstract

Cardio-renal syndrome in anemia is discussed with special emphasis of iron sucrose therapy.

References

  1. Ruggenenti P., Schieppatti A., Remuzzi G. Progression, regression, remission of renal diseases. Lancet 2001; 357: 1601 - 1608
  2. Baigent C., Burbury K., Wheeler D. Premature cardiovascular disease in chronic renal failure. Lancet 2000; 356: 147 - 152
  3. Ratcliffe P.J. Molecular biology of erythropoietin. Kidney Int. 1993; 44: 887 - 904
  4. Тареев Е.М. Анемия брайтиков. М., 1929, Издательство факультетской клиники 1 МГУ
  5. Silverberg D.S., Wexler D., Iaina A. The importance of anemia and its correction in the management of severe congestive heart failure Eur. J. Heart Fail. 2002; 4: 681 - 686
  6. Ronco C., McCullough P., Anker S.D. et al.; Acute Dialysis Quality Initiative (ADQI) consensus group. Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur. Heart J. 2010; 31(6): 703-711
  7. von Haehling S., Anker S.D. Cardio-renal anemia syndrome. Contrib. Nephrol. 2011; 171: 266-273
  8. Silverberg D.S., Wexler D., Blum M., Iania A. The cardio-renal syndrome: correcting anemia in patients with resistant congestive heart failure can improve both cardiac and renal function and reduce hospitalizations. Clin. Nephrol. 2003; 60: S93 - S102
  9. Levin A., Thompson C.R., Ethier J. et al. Left ventricular mass index increase in early renal disease: impact of decline of hemoglobin. Am. J. Kidney Dis. 1999; 34: 768 - 776
  10. Kazmi W., Kausz A., Khan S. et al. Anemia: an early complication of chronic renal insufficiency. Am. J. Kidney Dis. 2001; 38: 803 - 812
  11. Ezekowitz J.A., McAlister F.A., Armstrong P.W. Anemia is common in heart failure and is associated with poor outcomes insights from a cohort of 12 065 patients with new-onset heart failure. Circulation. 2003;107: 223 - 225
  12. Vaziri N.D. Erytropoetin and transferrin metabolism in nephrotic syndrome. Am. J. Kidney Dis. 2001; 38: 1 - 8
  13. Eschbach J.W. The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin. Kidney Int. 1989; 35: 134 - 148
  14. Foley R.N., Parfrey P.S., Harnett J.D. et al. The impact of anemia on cardiomyopathy, morbidity and mortality in end-stage renal disease. Am. J. Kidney Dis. 1996; 28: 53 - 61
  15. van der Meer P., van Gilst W.H., van Veldhuisen D.J. Anemia and congestive heart failure. Circulation 2003; 108: E41 - E42
  16. Cohen N., Gorelik O., Almoznino-Sarafian D. et al. Renal dysfunction in congestive heart failure, pathophysiological and prognostic significance. Clin. Nephrol. 2004; 61: 177 - 184
  17. Torre-Amione G., Bozkurt B., Deswal A. et al. An overview of tumor necrosis factor alfa and the failinig human heart. Curr. Opin. Cardiol. 1999; 14: 206 - 210
  18. Macdougall I.C. The role of ACE inhibitors and angiotensin II receptor blockers in the response to epoetin. Nephrol. Dial. Transplant. 1999; 14: 1836 - 1841
  19. Anand I.S., Chandrashekhar Y., Ferrari R. et al. Pathogenesis of edema in chronic anemia: studies of body water and sodium, renal function, haemodynamics and plasma hormones. Br. Heart J. 1993; 70: 357 - 362
  20. Weiskopf R.B., Viele M.K., Feiner J. et al. Human cardiovascular and metabolic response to acute, severe isovolemic anemia. J.A.M.A. 1998; 279: 217 - 221
  21. London G.M, Fabiani F., Marchais S.J. et al. Uremic cardiomyopathy: an inadequate left ventricular hypertrophy. Kidney Int. 1987; 31: 973 - 980
  22. Greaves S.C., Gamble G.D., Collins J.F. et al. Determinants of left ventricular hypertrophy and systolic dysfunction in chronic renal failure. Am. J. Kidney Dis. 1994; 24: 768 - 776
  23. Madore F., Lowrie E.G., Brugnara C. et al. Anemia in hemodialysis patients: variables affecting this outcome predictor. J. Am. Soc. Nephrol. 1997; 8: 1921 - 1929
  24. Козловская Л.В., Милованов Ю.С., Фомин В.В. et al. Анемическая кардиомиопатия. Анемия 2004; 1: 29 - 35
  25. McClellan W., Flanders W.D., Langston R.D. et al. Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. J. Am. Soc. Nephrol. 2002; 13: 1928 - 1936
  26. Horwich T.B., Fonarow G.C., Hamilton M.A. et al. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with left ventricular dysfunction. J. Am. Coll. Cardiol. 2002; 39: 1780 - 1786
  27. AlAhmad A., Rand W.M., Manjunath G. et al. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J. Am. Coll. Cardiol. 2003; 38: 955 - 962
  28. Anker S.D., Sharma R., The syndrome of cardiac cahexia. Int. J. Cardiol. 2002; 85: 51 - 66
  29. Anand I., McMurray J.J.V., Whitmore J. et al. Anemia and its relationship to clinical outcome in heart failure. Circulation 2004; 110: 149 - 154
  30. Deicher R., Horl W.H. Anaemia as a risk for the progression of chronic kidney disease. Curr. Opin. Nephrol. Hypertens. 2003; 12: 139 - 143
  31. Mohanram A., Zhang Z., Shahinfar S. et al. Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy. Kidney Int. 2004; 66:1131-1138
  32. Neff M.S., Kwan E.K., Persoff M. et al. Hemodynamics of uremic anemia. Circulation 1971; 43: 876 - 883
  33. Jungers P., Massy Z.A., Nguyen Khoa T. et al. Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study. Nephrol. Dial. Transplant. 1997; 12: 2597 - 2602
  34. Mac Mahon L.P., Mason K., Skinner S.L. et al. Effects of hemoglobin normalization on quality of life and cardiovascular parameters in end-stage renal failure. Nephrol. Dial. Transplant. 2000; 15: 1425 - 1430
  35. Macdougall I.C., Chandler G., Elston O., Harchowal J. Beneficial effects of adopting an aggressive intravenous iron policy in a haemodialysis unit. Am. J. Kidney Dis. 1999; 34 (Suppl. 2): S40 - S46
  36. Van Vyck D.B. Management of early renal anaemia: diagnostic work-up, iron therapy, epoetin therapy. Nephrol. Dial. Transplant. 2000; 15 (Suppl. 3): 36 - 39
  37. Sander-Plassmann G., Horl W. Importance of iron supply for erythropoietin therapy. Nephrol. Dial. Transplant. 1995; 10: 979 - 987
  38. Сharytan C., Levin N., Al-Saloum M. et al. Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anemia: North American Clinical Trial. Am. J. Kidney Dis. 2001; 37: 300 - 307
  39. Singh H., Reed J., Noble S., Cangiano J.L., Van Wyck D.B.; United States Iron Sucrose (Venofer) Clinical Trials Group. Effect of intravenous iron sucrose in peritoneal dialysis patients who receive erythropoiesis-stimulating agents for anemia: a randomized, controlled trial. Clin. J. Am. Soc. Nephrol. 2006; 1(3): 475-482
  40. Li H., Wang S.X. Intravenous iron sucrose in peritoneal dialysis patients with renal anemia. Perit. Dial. Int. 2008; 28(2): 149-154
  41. Malovrh M., Hojs N., Premru V. The influence of need-based, continuous, low-dose iron replacement on hemoglobin levels in hemodialysis patients treated with erythropoiesis-stimulating agents. Artif. Organs. 2011; 35(1): 63-68
  42. Solak Y., Atalay H., Guney I. Comparison of adverse-event profiles of intravenous low-molecular-weight iron dextran and iron sucrose in peritoneal dialysis patients. Ren. Fail. 2011; 33(3): 307-311
  43. Pollak V.E., Lorch J.A., Shukla R., Satwah S. The importance of iron in long-term survival of maintenance hemodialysis patients treated with epoetin-alfa and intravenous iron: analysis of 9.5 years of prospectively collected data. BMC Nephrol. 2009;10:6
  44. Comín-Colet J., Ruiz S., Cladellas M. et al. A pilot evaluation of the long-term effect of combined therapy with intravenous iron sucrose and erythropoietin in elderly patients with advanced chronic heart failure and cardio-renal anemia syndrome: influence on neurohormonal activation and clinical outcomes. J Card Fail. 2009; 15(9): 727-735

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies